æ ªåŒéå ¬éã®è£œè¬äŒç€ŸCeptaris Therapeuticsã¯ããªãŒãã¡ã³ãã©ãã°ãã²ã«è£œå€Valchlorãã®FDAæ¿èªãåŸãããšãçºè¡šããŸãããåè¬ã¯ãç®èç å€ã®æ²»ççµéšãæããæ£è ã«ãããèç¶æ¯èè «å(mycosis fungoides-type)ç®èT现èæ§ãªã³ãè «(cutaneous T-cell lymphomaïŒCTCL)ã®å±ææ²»çã«çšããããããšã«ãªããŸããValchlorã¯ã¡ã¯ãã¬ã¿ãã³(mechlorethamine)ã®åã®å€çšè¬ã§ãããäžè¬ã«ãã€ãããžã§ã³ãã¹ã¿ãŒã(nitrogen mustard)ãšããŠç¥ãããŠããŸããç®èã«1æ¥1åå±æçã«å¡åžããŸãã
ããã¯æ£è ãšæ²»çã³ãã¥ããã£ã«ãšã£ãŠè¯ãç¥ããã§ãããã
ã¡ã¯ãã¬ã¿ãã³ã¯ãCTCLã®æãäžè¬çãªã¿ã€ãã§ããèç¶æ¯èè «ã察象ãšãããé žéèæ²»çã§çšããããååŠçæ³å€ã§ããã¡ã¯ãã¬ã¿ãã³è£œå€ã¯æ©æCTCLã®æ²»çè¬ãšããŠå šç±³ç·åããæ å ±ãããã¯ãŒã¯(National Comprehensive Cancer Network)ã®æšå¥šãåããŠããŸããValchlorã®æ¿èªä»¥åã¯ãã¡ã¯ãã¬ã¿ãã³å€çšè¬ã§FDAã®èªå¯ãåŸãŠãããã®ã¯ãããŸããã§ããã
Valchlorãçšããããšã«ãããå»åž«ã¯ç æIA/IBã®èç¶æ¯èè «åCTCLãæ²»çã§ããããã«ãªããŸãã
ã¡ã¯ãã¬ã¿ãã³å€çšè¬ã®äœ¿çšã¯æ°å幎以äžã«ããã£ãŠå ±åãããŠããŸããããå³æ ŒãªFDAæ¿èªããã»ã¹ãåãæããã®ã¯ä»åãåããŠã§ããèŠæ Œåãšãªã£ãããšã§æ£è ããã®æ¯æãåãããããªãã§ãããã
Valchlorã¯å€çšè¬ãšããŠã®ã¿äœ¿çšãããŸãã现èæ¯æ§ãæããããšãããç®èçãç²èå·å®³ãç¶çºæ§ãããããããå±éºæ§ããããããæ£è 以å€ã®äººã¯ç®èã§çŽæ¥è§ŠããŠã¯ãããŸããããŸããã¡ã¯ãã¬ã¿ãã³ãæ·»å ç©ã«å¯ŸããŠé床ãŸãã¯å šèº«æ§ã®éæçãåããããšã®ããæ£è ã«ã¯çŠå¿ã§ããçŒãªã©ç²èãšã®æ¥è§Šãé¿ããªããã°ãªããŸãããã¡ã¯ãã¬ã¿ãã³ã«çŒãæ¥è§Šãããšãçã¿ãççãçŸæ(photophobia)ãèŠèŠã®ãŒããå Žåã«ãã£ãŠã¯é·æãã€é床ã®å·å®³ãçããããšããããŸããåãæ±ãã«ã¯åå泚æããå¿ èŠããããŸãã